Pharmacological management of attention-deficit hyperactivity disorder

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.5, Iss.6, 2004-06, pp. : 1313-1320

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological Management of Attention-Deficit Hyperactivity Disorder in Adolescents: Special Considerations

By Hazell Philip

CNS Drugs, Vol. 21, Iss. 1, 2007-01 ,pp. : 37-46

Adis International

Access to resources Recommend Favorite

Attention-Deficit Hyperactivity Disorder in Girls: Epidemiology and Management

By Staller Jud Faraone Stephen V.

CNS Drugs, Vol. 20, Iss. 2, 2006-01 ,pp. : 107-123

Adis International

Access to resources Recommend Favorite

Adverse Effects of Pharmacotherapies for Attention-Deficit Hyperactivity Disorder: Epidemiology, Prevention and Management

By Graham Johnny Coghill David

CNS Drugs, Vol. 22, Iss. 3, 2008-01 ,pp. : 213-237

Adis International

Access to resources Recommend Favorite

Progress and Promise of Attention-Deficit Hyperactivity Disorder Pharmacogenetics

By Froehlich Tanya E. McGough James J. Stein Mark A.

CNS Drugs, Vol. 24, Iss. 2, 2010-02 ,pp. : 99-117

Adis International

Access to resources Recommend Favorite

Drug Therapy for Adults with Attention-Deficit Hyperactivity Disorder

By Wilens T.E.

Drugs, Vol. 63, Iss. 22, 2003-01 ,pp. : 2395-2411

Adis International

Access to resources Recommend Favorite